Minister for Health announces HSE approval to reimburse patisiran (Onpattro)

12 July 2021 - The Minister for Health, Stephen Donnelly TD is pleased to announce that the drug patisiran (Onpattro) ...

Read more →

State slower to ‘adopt new drugs’ than most of western Europe

31 May 2021 - Medicines regularly not worth approving at asking price. ...

Read more →

Ireland an outlier without access to new cell and gene therapy, report says

27 May 2021 - Upfront costs high but treatments may cut long-term expense and boost patient results. ...

Read more →

Irish pharmacists lobby for biosimilar substitution

17 August 2020 - Pharmacists in Ireland say the country is losing out on hundreds of millions of dollars in savings ...

Read more →

Sacubitril/valsartan (Entresto) utilisation and prescribing patterns in the context of a reimbursement application system

12 June 2020 - The aim of this study was to evaluate the utilisation of Entresto in Ireland and compare patient ...

Read more →

Vertex and Republic of Ireland expand long-term cystic fibrosis medicines reimbursement agreement to include triple combination therapy for all eligible patients ages 12 and over once licensed

13 December 2019 - Vertex Pharmaceuticals today confirmed that, following recent collaborative discussions, it has negotiated an agreement with the ...

Read more →

In UK and Ireland, SMA patients demand reimbursement for Spinraza

6 March 2019 - A drug appraisal committee of Britain’s NICE met in Manchester, England, for the third and final ...

Read more →

Dublin warns medicine supply threatened by no-deal Brexit

16 January 2019 - More than half of Ireland’s medicines come from or are transited via the UK. ...

Read more →

Dublin ramps up bid to lure post-Brexit European Medical Agency

23 October 2017 - Ireland’s industrial development agency joins campaign to place EMA alongside republic’s burgeoning pharmaceutical and biomedical sectors. ...

Read more →